v3.26.1
Business Combination - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 05, 2026
May 31, 2026
May 31, 2025
May 31, 2024
Business Combination [Line Items]        
Number of shares sold in transaction (in shares) 1,311,407      
Price per share (in dollars per share) $ 12.01      
Consideration received on sale of stock $ 15,700      
Common stock issuance costs $ 800 $ 5,950 $ 10,305 $ 284
Goodwill   $ 54,513 $ 0  
EKSO Bionics Holdings, Inc.        
Business Combination [Line Items]        
Interest expected to be acquired (as percent) 100.00%      
Consideration transferred $ 57,600      
Number of shares calculated for reverse acquisition consideration (in shares) 4,357,026      
Closing price per share on acquisition date (in dollars per share) $ 13.22      
Accounts receivable, fair value $ 4,125      
Goodwill 54,513      
Goodwill deductible for tax purposes 500      
Acquisition related costs 5,300      
Total transaction costs incurred $ 5,300      
EKSO Bionics Holdings, Inc. | EKSO Bionics Holdings, Inc.        
Business Combination [Line Items]        
Closing price per share on acquisition date (in dollars per share) $ 13.22      
Fair value of noncontrolling interest $ 4,600      
EKSO Bionics Holdings, Inc. | ChronoScale Corporation        
Business Combination [Line Items]        
Ownership percentage 97.00%      
Noncontrolling owner 3.00%